A large pharmaceutical/biotechnology company wanted to better understand the product potential of an on-market, non-retail drug distributed through a limited network of specialty pharmacies and distributors in an active, competitive environment.

Viscadia was asked to build a custom forecast model that could integrate seamlessly with the client’s existing Latest Estimate (LE) process and that would also be versatile enough to support multiple stakeholders and the long-term brand planning process.